Clinical Trial Update: Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of Navarixin in combination with pembrolizumab in adults with selected advanced/metastatic solid tumors; trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Microsatellite-stable Colorectal Cancer
• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• Navarixin (navarixin)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Solid Tumors, Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-06-29